Additionally, chitosan/hyaluronic acid nanogels functionalized with endothelin-1 and bradykinin receptor antagonist peptides (BQ-123 and R-954) have been explored for osteoarthritis treatment, leveraging these peptides’ ability to modulate joint inflammation and pain signaling [85]. The gene discussed is EDN1; the disease is osteoarthritis.